Blood Pressure Lowering Effect of Cuban Policosanol is Accompanied by Improvement of Hepatic Inflammation, Lipoprotein Profile, and HDL Quality in Spontaneously Hypertensive Rats
Open Access
Abstract
We investigated the antihypertensive effect of policosanol on spontaneously hypertensive rats (SHR). For this, we analyzed blood pressure, blood lipid, and lipoprotein properties in male SHR after consumption of Cuban policosanol (PCO). The experimental groups were as follows: normotensive Wistar Kyoto (WKY) control, SHR group fed normal diet (ND), SHR group fed 20 mg of PCO, SHR group fed 100 mg of PCO, and SHR group fed 200 mg of PCO per kg of body weight. After eight weeks, the SHR control group showed gradual increases up to 22% in systolic blood pressure (SBP) and 17.6% in the diastolic blood pressure (DBP) compared with values at week 0. However, policosanol consumption had a dose-dependent reduction effect on SBP and also reduced DBP up to 16% in a dose-dependent manner. Heart rate (HR) bpm increased by six percent in the SHR control, whereas the 20 mg, 100 mg, and 200 mg of policosanol groups showed a reduction of 36%, 28%, and 34% respectively. Although serum total cholesterol (TC) level of SHR was not affected by policosanol consumption (70–80 mg/dL), serum triglyceride (TG) level significantly decreased in the SHR + 200 mg of PCO group. Serum high-density lipoprotein cholesterol (HDL-C) level was also significantly elevated by policosanol consumption. The % HDL-C/TC ratio was elevated in the policosanol group up to 67–70%, whereas the SHR control group showed a ratio of 58%. Serum cholesteryl ester transfer protein (CETP) activity was reduced by policosanol in a dose-dependent manner. Although the serum glutamate oxaloacetate transaminase (GOT)/ glutamate pyruvate transaminase (GPT) were similar across all groups, policosanol consumption caused reduction of reactive oxygen species (ROS) levels in hepatic tissue. The SHR control group showed a 2.1-fold higher serum C-reactive protein (CRP) level than the WKY group, whereas the CRP level decreased in the SHR + 200 mg of PCO group (up to 45%) than SHR control group. Aldosterone level was reduced in the policosanol group (up to 34%) in a dose-dependent manner compared to the control. In conclusion, eight weeks of policosanol consumption in SHR resulted in remarkable reduction of blood pressure, serum aldosterone, and serum TG levels along with the elevation of HDL-C and improvement of hepatic inflammation.Keywords
This publication has 44 references indexed in Scilit:
- Torcetrapib impairs endothelial function in hypertensionEuropean Heart Journal, 2011
- Circulating plasma cholesteryl ester transfer protein activity and blood pressure tracking in the communityJournal Of Hypertension, 2011
- Effects of Human C-Reactive Protein on Pathogenesis of Features of the Metabolic SyndromeHypertension, 2011
- The Renin Angiotensin Aldosterone System in Hypertension: Roles of Insulin Resistance and Oxidative StressMedical Clinics of North America, 2009
- Synthesis of Reconstituted High Density Lipoprotein (rHDL) Containing apoA-I and apoC-III: the Functional Role of apoC-III in rHDLMolecules and Cells, 2009
- Myocardial infarction patients show altered lipoprotein properties and functions when compared with stable angina pectoris patientsExperimental & Molecular Medicine, 2009
- Dyslipidaemia as a predictor of hypertension in middle-aged menEuropean Heart Journal, 2008
- Blood Volume Measurement as a Tool in Diagnosing SyncopeThe American Journal of the Medical Sciences, 2007
- Policosanol Inhibits Cholesterol Synthesis in Hepatoma Cells by Activation of AMP-KinaseThe Journal of Pharmacology and Experimental Therapeutics, 2006
- Circadian blood pressure variation in transgenic hypertensive rats.Hypertension, 1993